Amsterdam Neuroscience

The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community

EANM Neuroimaging Committee, Sept 2021, In: European journal of nuclear medicine and molecular imaging. 48, 10, p. 3033-3036 4 p.

Research output: Contribution to journal › Editorial* › Academic › peer-review

Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study: The CAPTAINs Study

Bischof, G. R. N., Bartenstein, P., Barthel, H., van Berckel, B., Doré, V., van Eimeren, T., Foster, N., Hammes, J., Lammertsma, A. A., Minoshima, S., Rowe, C., Sabri, O., Seibyl, J., van Laere, K., Vandenberghe, R., Villemagne, V., Yakushev, I. & Drzezga, A., 1 Jul 2021, In: Journal of nuclear medicine. 62, 7, p. 999-1005 7 p.

Research output: Contribution to journal › Article* › Academic › peer-review

Molecular imaging approaches in dementia

Villemagne, V. L., Barkhof, F., Garibotto, V., Landau, S. M., Nordberg, A. & van Berckel, B. N. M., 1 Mar 2021, In: Radiology. 298, 3, p. 517-530 14 p.

Research output: Contribution to journal › Review article* › Academic › peer-review